Management of gestational diabetes

Clinics in Perinatology

Volumn 20, Issue 3, 1993, Pages 603-617

  Langer, O ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; ORAL ANTIDIABETIC AGENT;

DIET THERAPY; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN TREATMENT; ORAL DRUG ADMINISTRATION; PATHOGENESIS; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0027376657     PISSN: 00955108     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0095-5108(18)30388-9     Document Type: Review

References (66)

1. American Diabetes Association Second International Workshop-Conference on Gestational Diabetes Mellitus, Summary and Recommendations Diabetes 34 1985 123 126
2. Bergman R.N. Beard J.C. Chen M. The minimal modeling method: Assessment of insulin sensitivity and B-cell function in vivo Methods in Diabetes Research 11 1986 15 35
3. Bergman R.N. Lilly lecture 1989: Toward physiological understanding of glucose tolerance: Minimal model approach Diabetes 38 1989 1512 1527
4. Berkus M.D. Langer O. Glucose tolerance test: Degree of glucose abnormality correlates with neonatal outcome Obstet Gynecol 81 1993 344 348
5. Berkus M.D. Stem M.P. Mitchell B.D. Relationships between glucose levels and insulin secretion during glucose challenge test Am J Obstet Gynecol 163 1990 1818 1822
6. Brunzell J.D. Robertson R.P. Lerner R.L. Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests J Clin Endocrinol Metab 42 1976 222 229
7. Brustrnan L. Langer O. Engel S. Verified self-monitored blood glucose data versus glycosylated hemoglobin and glycosylated serum protein as a means of predicting short and long term metabolic control in gestational diabetes Am J Obstet Gynecol 157 1987 699 703
8. Bung P. Artal R. Nazareth K. Exercise in gestational diabetes: An optional therapeutic approach? Diabetes 40 1991 182 185
9. Catalano P.M. Bernstein I.M. Wolfe R.R. Subdinical abnormalities of glucose metabolism in subjects with previous gestational diabetes Am J Obstet Gynecol 155 1986 1255 1262
10. Coustan D.R. Imarah J. Fetus, placenta, and newborn: Prophylactic insulin treatment of gestational diabetes reduces the incidence of macrosomia, operative delivery, and birth trauma Am J Obstet Gynecol 150 1984 836 842
11. DeFronzo R.A. Ferrannini E. Koivisto V. New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus Am J Med 17 1983 52 81
12. DeFronzo R.A. Ferrannini E. Simonson D.C. Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: Contributions of excessive hepatic glucose production and impaired tissue glucose uptake Metabolism 38 1989 387 395
13. DeFronzo R.A. Tobin J.D. Andres R. Glucose clamp technique: A method for quantifying insulin secretion and resistance Am J Physiol 237 1979 E214 223
14. Durak E.P. Jovanovic-Peterson L. Peterson C.M. Physical and glycemic responses of women with gestational diabetes to a moderately intense exercise program Diabetes Education 16 1990 309 312
15. Ellenberg M. Rifkin H. Diabetes Mellitus, Theory and Practice ed 3 1983 Medical Examination Publishing New York
16. Elliott B. Schenker S. Langer O. Oral hypoglycemia agents: Profound variation exists in their rate of human placental transfer Proceedings of the 12th Annual Meeting of the Society of Perinatal Obstetricians 1992 Society of Perinatal Obstetricians Orlando, FL February
17. Elliott B.D. Bynum D. Langer O. Glyburide does not cross the diabetic placenta in significant amounts Proceedings of the 13th Annual Meeting of the Society of Perinatal Obstetricians 1993 Society of Perinatal Obstetricians San Francisco, CA February
18. Elliott B.D. Bynum D. Langer O. Maternal hyperglycemia does not alter in-vitro placental transfer of the oral hypoglycemic agent glyburide Proceedings of the Society of Perinatal Obstetricians 1993 Society of Perinatal Obstetricians San Francisco, CA February
19. Elliott B.D. Langer O. Schenker S. Insignificant transfer of glyburide occurs across the human placenta Am J Obstet Gynecol 165 1991 807 812
20. Ferrannini E. The theoretical bases of indirect calorimetry: A review Metabolism 37 1988 287 301
21. Frayn K.N. Calculation of substrate oxidation rates in vivo from gaseous exchange J Appl Physiol 55 1983 628 634
22. Freinkel N. Metzger B.E. Phelps R.L. Gestational diabetes mellitus: Heterogeneity of maternal age, weight, insulin secretion, HLA antigens, and islet cell antibodies and the impact of maternal metabolism on pancreatic B-cell and somatic development in the offspring Diabetes 34 1985 1 7
23. Freinkel N. Metzger B.E. Pregnancy as a tissue culture experience: The critical implications of maternal metabolism for fetal development Ciba Found Symp 63 1979 3 23
24. Freinkel N. Banting lecture: Of pregnancy and progeny Diabetes 29 1980 1023 1035
25. Fuhrmann K. Reiher H. Semmler K. Prevention of congenital malformation in infants of insulin dependent diabetic mothers Diabetes Care 6 1983 219 223
26. Gyves M.T. Rodman H.M. Little A.B. A modem approach to management of pregnant diabetics: A two-year analysis of perinatal outcomes Am J Obstet Gynecol 128 1977 606 616
27. Jacobson J.D. Cousins L. A population-based study of maternal and perinatal outcome in patients with gestational diabetes Am J Obstet Gynecol 161 1989 981 986
28. Jovanovic L. Druzin M. Peterson C.M. Effect of euglycemia on the outcome of pregnancy in insulin-dependent diabetic women as compared with normal control subjects Am J Med 71 1982 921
29. Jovanovic-Peterson L. Durak E.P. Peterson C.M. Randomized trial of diet versus diet plus cardiovascular conditioning on glucose levels in gestational diabetes Am J Obstet Gynecol 161 1989 415 419
30. Jovanovic-Peterson L. Peterson C.M. Is exercise safe or useful for gestational diabetic women? Diabetes 40 1991 179 181
31. Kahn C.R. Insulin resistance: A common feature of diabetes mellitus N Engl J Med 315 1986 252 254
32. Karlsson K. Kjellmer I. The outcome of diabetic pregnancies in relation to the mother’s blood sugar level Am J Obstet Gynecol 112 1972 213 220
33. Landon M.B. Gabbe S.G. Piana R. Neonatal morbidity in pregnancy complicated by diabetes mellitus: Predictive value of maternal glycemic profiles Am J Obstet Gynecol 156 1987 1089 1095
34. Landon M.B. Gabbe S.G. Sachs L. Management of diabetes mellitus and pregnancy: A survey of obstetricians and maternal-fetal specialists Obstet Gynecol 75 1990 635 640
35. Langer O. Anyaegbunam A. Brustman L. A prospective randomized study: Management of women with one abnormal oral glucose tolerance test value reduces adverse outcome in pregnancy Am J Obstet Gynecol 161 1989 593 599
36. Langer O. Anyaegbunam A. Brustman L. Pregestational diabetes: Insulin requirements throughout pregnancy Am J Obstet Gynecol 159 1988 616 620
37. Langer O. Anyaegbunam A. Brustman L. Gestational diabetes: Insulin requirements in pregnancy Am J Obstet Gynecol 157 1987 669 675
38. Langer O. Berkus M. Brustman L. The rationale for insulin management in gestational diabetes mellitus Diabetes 40 1991 186 190 (S2)
39. Langer O. Brustman L. Anyaegbunam A. The significance of one abnormal glucose tolerance test value on adverse outcome in pregnancy Am J Obstet Gynecol 157 1987 758 763
40. Langer O. Brustman L. Anyaegbunam A. Glycemic control in gestational diabetes mellitus—how tight is tight enough: For gestational age versus large for gestational age? Am J Obstet Gynecol 161 1989 645 653
41. Langer O. Damus K. Maiman M. A link between relative hypoglycemia-hypoinsulin- emia during OGTT and intrauterine growth retardation Am J Obstet Gynecol 155 1986 711 718
42. Langer O. Mazze R. The relationship between glycosylated hemoglobin and verified self-monitored blood glucose among pregnancy and non-pregnant women with diabetes Practical Diabetes 4 1987 32 33
43. Langer O. Mazze R. The relationship between large-for-gestational-age infants and glycemic control in women with gestational diabetes Am J Obstet Gynecol 159 1979 1478 1483
44. Langer O. Mazze R.S. Anyaegbunam A. Improvement of self-monitoring blood glucose performance in pregnancy diabetics Proceedings of the 7th Annual Meeting of the Society of Perinatal Obstetricians 1987 Society of Perinatal Obstetricians Orlando, FL
45. Langer O. Mazze R.S. Diabetes in pregnancy: Evaluating self-mordtoring performance and glycemic control with memory-based reflectance meters Am J Obstet Gynecol 155 1986 635 637
46. Langer O. Mazze R.S. Variation in insulin response in gestational diabetes: Natural progress of one disease Proceedings of the 34th Annual Meeting of the Society for Gynecologic Investigation 1987 Society for Gynecologic Investigation Atlanta, GA
47. Langer O. Miodovnik M. Gross B. Ambulatory glucose profile of the pregnant non-diabetic Proceedings of the Society for Gynecologic Investigation 1989 Society for Gynecologic Investigation San Diego, CA
48. Langer O. A scientific rationale for the management of diabetes in pregnancy: Recent approaches using innovative computer-based technology Diabetes Care 11 1988 67 72
49. Langer O. Critical issues in diabetes and pregnancy: Early identification, metabolic control, and prevention of adverse outcome Merkatz I.R. Thompson J.E. Mullen P.D. New Perspectives on Prenatal Care 1991 Elsevier Science Publications New York 445 459
50. Langer O. Diabetes in pregnancy Merkatz I.R. Cherry S.H. Medical, Surgical and Gynecologic Complications of Pregnancy ed 4 1991 Williams & Wilkins Baltimore
51. Langer O. Fetal macrosomia: Etiological factors Divon M. Abnormal Fetal Growth 1991 Elsevier Science Publications New York 99 110
52. Langer O. Prevention of macrosomia Oats J.N. Diabetes in Pregnancy 1991 WB Saunders Philadelphia 333 347
53. Lavin J.P. Lovelace D.R. Miodovnik M. Clinical experience with one hundred and seven diabetic pregnancies Am J Obstet Gynecol 147 1983 742 752
54. Management of diabetes mellitus in pregnancy ACOG Tech Bull 92 1986 1 5
55. Mazze R. Langer O. Primary, secondary and tertiary prevention: A program for diabetes in pregnancy Diabetes Care 11 1988 263 268 (S3)
56. Metzger B.D. Silverman B.I. Freinkel N. Amniotic fluid insulin concentration as a predictor of obesity Diabetes 32 1984 210
57. Metzger B.E. Bybee D.E. Freinkel N. Gestational diabetes mellitus: Correlations between the phenotypic and genotypic characteristics of the mother and abnormal glucose tolerance during the first year postpartum Diabetes 34 1985 111 115
58. Miodovnik M. Mimouni F. Tsang R.C. Glycemic control and spontaneous abortion in insulin-dependent diabetic women Obstet Gynecol 68 1986 366 369
59. Olefsky J. Kolterman O.G. Scarlett J.A. Insulin action and resistance in obesity and noninsulin-dependent type II diabetes mellitus Am J Physiol 243 1982 E15 30
60. O’Sullivan J.B. Synder P.J. Sporer A.C. Intravenous glucose tolerance test and its modifications by pregnancy J Clin Endocrinol 31 1970 33 37
61. Pederson J. The Pregnant Diabetic and Her Newborn: Problems and Management ed 2 1977 Williams & Wilkins Baltimore 211 220
62. Roversi G.D. Gargiulo M. Nicolini U. Maximal tolerated insulin therapy in gestational diabetes Diabetes Care 3 1980 489 494
63. Roversi G.D. Gargiulo M. Nicolini U. A new approach to the treatment of diabetic pregnant women Am J Obstet Gynecol 135 1979 567 576
64. Ryan E.A. O’Sullivan M.J.O. Skyler J.S. Insulin action during pregnancy: Studies with the euglycemic clamp technique Diabetes 34 1985 380 389
65. Schwartz J.G. Phillips W.T. Langer O. Use of a more physiologic oral glucose solution during testing for gestational diabetes mellitus Am J Clin Pathol 97 1992 831 835
66. Yki-Jarvinen H. Koivisto V.A. Natural course of insulin resistance in type I diabetics N Engl J Med 315 1986 224